---
figid: PMC3604032__nihms423317f1
figtitle: PI3K/Akt/mTOR signaling in breast cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3604032
filename: nihms423317f1.jpg
figlink: /pmc/articles/PMC3604032/figure/F1/
number: F1
caption: 'PI3K/Akt/mTOR signaling in breast cancer. Alterations at different nodes
  of the pathway have been implicated in breast cancer development and progression.
  Inhibitors targeting the pathway are being studies in clinical trials. Arrows represent
  activation; bars represent inhibition.Abbreviations: 4E-BP1, 4E-binding protein
  1; AMPK, adenosine monophosphate-activated protein kinase; FOXO, forkhead box O1;
  GSK3β, glycogen synthase kinase 3; INPP4B, inositol polyphosphate-4-phosphatase;
  IRS1, insulin receptor substrate 1; mTOR, mammalian target of rapamycin; mTORC1,
  mTOR complex 1; mTORC2, mTOR complex 2; PI3K, phosphatidylinositol 3-kinase; PIP2,
  phosphatidylinositol (4,5) bisphosphate; PIP3, phosphatidylinositol (3,4,5) trisphosphate;
  PTEN, phosphatase and tensin homolog; Rheb, Ras homolog enriched in brain; S6K,
  ribosomal protein S6 kinase; TSC1, tuberous sclerosis complex 1; TSC2, tuberous
  sclerosis complex 2.'
papertitle: Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors
  in breast cancer.
reftext: A. M. Gonzalez-Angulo, et al. Cancer Treat Rev. ;39(4):313-320.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9266927
figid_alias: PMC3604032__F1
figtype: Figure
redirect_from: /figures/PMC3604032__F1
ndex: 3e32ceb4-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3604032__nihms423317f1.html
  '@type': Dataset
  description: 'PI3K/Akt/mTOR signaling in breast cancer. Alterations at different
    nodes of the pathway have been implicated in breast cancer development and progression.
    Inhibitors targeting the pathway are being studies in clinical trials. Arrows
    represent activation; bars represent inhibition.Abbreviations: 4E-BP1, 4E-binding
    protein 1; AMPK, adenosine monophosphate-activated protein kinase; FOXO, forkhead
    box O1; GSK3β, glycogen synthase kinase 3; INPP4B, inositol polyphosphate-4-phosphatase;
    IRS1, insulin receptor substrate 1; mTOR, mammalian target of rapamycin; mTORC1,
    mTOR complex 1; mTORC2, mTOR complex 2; PI3K, phosphatidylinositol 3-kinase; PIP2,
    phosphatidylinositol (4,5) bisphosphate; PIP3, phosphatidylinositol (3,4,5) trisphosphate;
    PTEN, phosphatase and tensin homolog; Rheb, Ras homolog enriched in brain; S6K,
    ribosomal protein S6 kinase; TSC1, tuberous sclerosis complex 1; TSC2, tuberous
    sclerosis complex 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Akt
  - SNF4Agamma
  - AMPKalpha
  - gig
  - Tsc1
  - Mtor
  - Tor
  - Rheb
  - sgg
  - Axn
  - gskt
  - foxo
  - Low
  - Crtc
  - Thor
  - S6k
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC2
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - GSK3B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RPTOR
  - EIF4EBP1
  - RPS6KB1
  - rapamycin
  - Cancer
---
